Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2664 | 2947 | 32.2 | 53% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
443 | 24079 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//VITAMIN A |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | METHYLSULFONYLMETHANE | Author keyword | 21 | 69% | 1% | 18 |
2 | LEUKEMIA CELL DIFFERENTIATION | Author keyword | 17 | 100% | 0% | 8 |
3 | N ACETYL S N METHYLCARBAMOYLCYSTEINE | Author keyword | 17 | 100% | 0% | 8 |
4 | N HYDROXYMETHYL N METHYLFORMAMIDE | Author keyword | 8 | 100% | 0% | 5 |
5 | N METHYLFORMAMIDE | Author keyword | 7 | 27% | 1% | 22 |
6 | N N DIMETHYLFORMAMIDE | Author keyword | 6 | 14% | 1% | 40 |
7 | HEXAMETHYLENE BISACETAMIDE | Author keyword | 5 | 42% | 0% | 10 |
8 | CANCER PREVENTION EFFICACY | Author keyword | 4 | 75% | 0% | 3 |
9 | INVOLUCRIN EXPRESSION | Author keyword | 4 | 75% | 0% | 3 |
10 | MED SCI SLOAN KETTERING | Address | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | N ACETYL S N METHYLCARBAMOYL CYSTEINE | 15 | 82% | 0% | 9 |
2 | SYNTHETIC LEATHER WORKERS | 15 | 88% | 0% | 7 |
3 | DIFFERENTIATION INDUCING PROTEIN | 15 | 73% | 0% | 11 |
4 | T 61 | 10 | 73% | 0% | 8 |
5 | N METHYLFORMAMIDE | 8 | 19% | 1% | 40 |
6 | DIMETHYLFORMAMIDE | 8 | 11% | 2% | 69 |
7 | NSC 95580 | 8 | 100% | 0% | 5 |
8 | DIMETHYL SULFONE | 7 | 46% | 0% | 12 |
9 | MEL CELLS | 7 | 57% | 0% | 8 |
10 | HETEROGENEOUS RESPONSE | 6 | 80% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HUMAN-LEUKEMIC MODELS OF MYELOMONOCYTIC DEVELOPMENT - A REVIEW OF THE HL-60 AND U937 CELL-LINES | 1985 | 631 | 60 | 48% |
METABOLISM OF N,N-DIMETHYLFORMAMIDE - KEY TO THE UNDERSTANDING OF ITS TOXICITY | 1993 | 62 | 34 | 85% |
Pharmacology of dimethyl sulfoxide in cardiac and CNS damage | 2009 | 32 | 60 | 47% |
Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis | 2008 | 29 | 30 | 53% |
The control of hematopoiesis and leukemia: From basic biology to the clinic | 1996 | 94 | 83 | 34% |
Tanax (R) (T-61): An overview | 2000 | 13 | 19 | 95% |
The Role of Oxidative Stress in the Aging Process | 2010 | 40 | 22 | 18% |
DIMETHYLSULFOXIDE (DMSO) - A REVIEW | 1986 | 137 | 41 | 66% |
INDUCTION OF DIFFERENTIATION OF HUMAN ACUTE MYELOGENOUS LEUKEMIA-CELLS - THERAPEUTIC IMPLICATIONS | 1983 | 579 | 54 | 54% |
Cytokine control of developmental programs in normal hematopoiesis and leukemia | 2002 | 72 | 139 | 23% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED SCI SLOAN KETTERING | 4 | 75% | 0.1% | 3 |
2 | BIOQUIM ENVELHECIMENTO DOENCAS CORRELACIONA | 2 | 67% | 0.1% | 2 |
3 | NPPG | 2 | 50% | 0.1% | 3 |
4 | SO BUR | 2 | 50% | 0.1% | 3 |
5 | KRASNODAR BRANCH | 2 | 43% | 0.1% | 3 |
6 | MICROBIOL IMMUNOL MOL GENET A68 | 1 | 100% | 0.1% | 2 |
7 | SEZ MED LAVORO 2 | 1 | 50% | 0.1% | 2 |
8 | VRT | 1 | 50% | 0.1% | 2 |
9 | CELLULAR MOL TOXICOL PROGRAM | 1 | 33% | 0.1% | 2 |
10 | LRF DIFFERENTIAT PROGRAMME | 1 | 33% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016373 | EMBRYONAL CARCINOMA//TERATOCARCINOMA//HNT |
2 | 0.0000013097 | ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO |
3 | 0.0000010304 | EXPERIMENTAL HEMATOLOGY//G CSF//PLERIXAFOR |
4 | 0.0000009503 | CELL TRANSFORMATION ASSAY//ONCOGENIC RAS P21//BHAS 42 CELLS |
5 | 0.0000009056 | NEUROCHEM NEUROBIOL//GLIA MATURATION FACTOR//GLIA MATURATION FACTOR GMF |
6 | 0.0000008581 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
7 | 0.0000008130 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
8 | 0.0000007662 | VITAMIN D//25 HYDROXYVITAMIN D//VITAMIN D DEFICIENCY |
9 | 0.0000006969 | VITAMIN A//RETINOIC ACID//RETINOIDS |
10 | 0.0000006810 | PHOSPHOLIPASE D//DIACYLGLYCEROL KINASE//PROTEIN KINASE C |